Pharmafile Logo
Pharmafocus logo
Advanced Search
Clavis Olav Hellebo

Clavis Pharma appoints Olav Hellebø

January 25, 2010
Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing

Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …

Appointment
Turkey flag

2010 and beyond

January 25, 2010
Sales and Marketing em, emerging markets, industry

The global pharma market is expected to grow between 4 to 6% on a constant dollar basis and is expected …

News

Patient access scheme secures NICE approval for Cimzia

January 22, 2010
Sales and Marketing Cimzia, NICE, UCB, rheumatoid arthritis

UCB Pharma’s Cimzia has been recommended by NICE to treat rheumatoid arthritis – but only if a patient access scheme …

News
Blog footer

Digital Pharma – Byte-sized roundup

January 22, 2010
Medical Communications Fresenius Kabi, P&G, Prilosec OTC, Seroquel, Twitter, digital pharma

In this week’s roundup: P&G taps social media for Prilosec OTC, UK launches new data site, analysis of pharma on …

News

Tudor Reilly opens first London office

January 22, 2010
Medical Communications Tudor Reilly

Beaconsfield-based healthcare PR agency Tudor Reilly has opened its a second office in Baker Street, London.The healthcare communications consultancy, which is …

News
Moscow's Red Square

Russia’s health drive to help pharma growth

January 22, 2010
Sales and Marketing Russia, em, emerging markets, industry

Russia endured a turbulent 2009 in economic terms, thanks to the steep drop in oil prices, but the country is …

Feature

PDS appoints Graham Clapperton

January 22, 2010
Research and Development PDS, appointment, research and development

Pharmaceutical Development Services Ltd (PDS) has appointed Graham Clapperton to head up its quality services. Graham joins the Nottingham, UK-based consultancy …

Appointment

Management Forum Announces Pharmacy in Practice Conference Chair and Science in Pharmacy Conference Chair

January 21, 2010
Research and Development

David Pruce former Director of Policy & Communications with The Royal Pharmaceutical Society of Great Britain will chair Management Forum’s …

News
Press release
Red Cross aid

More pharma aid sent to Haiti

January 21, 2010
Research and Development, Sales and Marketing Haiti, disaster, relief

A week after the devastating earthquake in Haiti the number pharma companies sending aid to the stricken country continues to …

News
clive-dix

Clive Dix appointed chairman of Crescendo Biologics

January 21, 2010
Research and Development Crescendo Biologics, appointment, research and development

Cambridge, UK-based Crescendo Biologics has appointed Clive Dix as chairman. He will work closely with chief scientific officer Mike Romanos …

Appointment

GSK launches ‘Open Lab’ to share resources

January 21, 2010
Research and Development, Sales and Marketing Africa, GlaxoSmithKline, malaria

GlaxoSmithKline has announced a series of measures to help improve medical treatment in poor countries. It has set up an …

News

Merck invests in one plant, DSM shutters another

January 21, 2010
Manufacturing and Production API, DSM, Merck KGaA, ingredients, intermediates

German chemical and pharmaceutical company Merck KGaA is planning to set up a plant to make inorganic salts used in …

News

Lisa Pantelli joins Spink

January 21, 2010
Medical Communications Spink, appointment, medical communications

Healthcare PR agency Spink has hired Lisa Pantelli for its rapidly expanding consumer healthcare division. With over six years blue …

Appointment
Blog footer

Digital Pharma: Glucose monitoring for the Nintendo generation

January 20, 2010
Medical Communications Bayer, diabetes, digi, digi game, digital pharma

The Nintendo DS that arrived in our house on Christmas has already become my eldest son’s most favourite present of …

Feature

Marketing in rare diseases – getting closer to your customers

January 20, 2010
Sales and Marketing Orphan, marketing, marketing ideas, niche

The 21st century healthcare industry is reorientating its strategic focus on the increasingly successful areas of orphan and rare diseases. …

Feature

Triple approval for Novartis in Japan

January 20, 2010
Sales and Marketing Afinitor, Asia, Exforge, Galvus, Japan, Novartis, hypertension

Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …

News
BreconMD

Peter Belden appointed MD of Brecon Pharmaceuticals

January 20, 2010
Manufacturing and Production Brecon, appointment, manufacturing and production

Commercial packaging and clinical trials supplies services company Brecon Pharmaceuticals has appointed Peter Belden managing director. He was previously senior …

Appointment

Obama presses on in spite of public doubts

January 20, 2010
Sales and Marketing Obama, US healthcare

President Obama is making slow but steady progress towards making his healthcare reforms a reality – but is also steadily …

News

Lundbeck and Teva launch Azilect in France

January 20, 2010
Sales and Marketing Azilect, France, Lundbeck, Teva

Lundbeck and Teva France have launched Azilect in France following the successful conclusion of pricing and reimbursement discussions with the …

News

FDA to study effects of medication during pregnancy

January 20, 2010
Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026